After you sell your 34 shares lighten up on your posts as well. We will all benefit from that.
You few hundred shares of INFN hardly seems worth the wasted time you feel compelled to spend on this board. Get 50k shares or more then you can prove why you even exist on this or any board.
Why don't YOU stop posting and replying to your own posts. You just ramble on forever. WHY?
Whatever... the stock is down almost a $1 in the last two trading days and almost $5 since the last CC. Until the next CC don't expect any comments from INFN. They simply need to show some sustainable growth across all platforms. The numbers aren't that bad but for whatever reason the market is not satisfied.
Don't hold your breathe for a whale since 98% of customers are rarely announced. However increased revs and a strong guidance will move this ship off the pier.
If it makes anyone sleep better at night believing I didn't work at both INFN and before that Lightera/CIEN then help yourself to that thought. Whats to be gained on my part to lie? As far as JNJ. My wife has worked there for over 25 years. So during that time through stock options, RSUs and stock compensated bonuses we have accumulated a very nice position in JNJ over those 25 years. These things happen. Now that you know you can go back and focus on your life and make it the best you can.
It typically takes a day or two to fund into your broker account. It rarely shows up the day the dividend actually pays out.
I don't notice nor care what people do or say. The internet isa sort of bully's alley for most. That's how they provide themselves with some sort of satisfaction of hating on people they don't even know. It's quite amazing but it is what it is. Have a great day all and keep reinvesting those dividends. Keep growing your wealth.
I agree drugs are not inline with what consumers need in order to get good health care. In other countries like Canada the same drugs that are sold in the US can cost sometimes 50% less. So although I agree with the fact that to bring a breakthrough drug to market can cost billions, companies need to make it more affordable and not burden the system with outrageous drug costs.
Because right now the company is being perceived as a slow growth stock. It shouldn't since it's growing at over 20% a year. However its piers are overperforming. They are simply not taking advantage of the recent uptick in the market. Eventually the market will turn negitive and INFN will go down with it. Possibly hitting new lows.